In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

AlphaRx > Message
Moneyshirt

Re: NEWS - AlphaRx Announces Debt Conversion

Posted by: jackfree on September 28, 2007 12:31PM

In response to: NEWS - AlphaRx Announces De... by AGORACOM

This seems like good news it is always nice to get rid of dept.  I wonder if this goes against the float.  Also what the restrictions are for these shares.  It is also strange that the price is at .05 or maybe this happened when the price was lower and they just announced it now.  Many questions few answers about the various R+D area that we care about.
Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote